Stanley Lapidus has resigned from his position on Helicos' board of directors. Lapidus, a Helicos co-founder, served as CEO of the company until 2008 and was chairman of the board until he stepped down from that spot last year. According to documents filed with the US Securities Exchange Commission, he did not resign due to any disagreement with the company.
Lapidus is currently the founder, president, and CEO of SynapDx , a startup developing diagnostic tests for the early detection of autism. Prior to Helicos, he founded several companies including applied genomics company Exact Sciences and Cytyc, which merged with Hologic in 2007.
Lapidus also holds academic appointments in the pathology department at Tufts University Medical School and MIT's Sloan School of Management.
Boreal Genomics has appointed Nitin Sood to CEO and member of the board of directors. Sood joins Boreal Genomics from Agilent Technologies, where he served most recently as general manager of the automation business. He has more than 15 years of experience including in senior management positions at Applied Biosystems. He holds an MS in computer science and molecular biology.
The board of the Center for Genomic Regulation in Spain has named Luis Serrano director for an initial term of five years. He replaces Miguel Beato, who has headed the institute for the past 10 years.
Serrano currently heads the systems biology program at the Center for Genomic Regulation. He was previously group leader at the European Molecular Biology Laboratory and structural and computational biology program manager between the EMBL and the Spanish National Cancer Research Center. He holds a PhD in biochemistry from the Autonomous University of Madrid.